Stian Kildal CEO

Roles

OncoZenge AB Stockholm
CEO
26.08.202528.11.2025

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
28.11.2025OncoZenge AB Stockholm
Bought — open marketAcquisition
74,999SEK 5.30
SEK 397,494.70
09.09.2025OncoZenge AB Stockholm
Bought — open marketAcquisition
25,000SEK 6.30
SEK 157,500.00
26.08.2025OncoZenge AB Stockholm
Bought — open marketAcquisition
25,001SEK 6.94
SEK 173,506.94